VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > VMS+4.0, to Health Canada for approval! 🎉

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Aug 15, 2024 9:41am

70 Views

Post# 36180299

RE:RE:VMS+4.0, to Health Canada for approval! 🎉

jopatclo wrote: I think of exciting moments. FDA V4.0 and Sales at any time now Insiders know!Post Bart Hendriks I'm excited to share that Ventripoint has just submitted its latest AI-powered heart-scanning technology, VMS+4.0, to Health Canada for approval! This new version is designed to seamlessly integrate into clinical workflows.

and Always confident for GEHC, as for China! Interesting (VMS+2.0 is being manufactured and used in leading hospitals in China through a partnership). those thought this partnership was dead! For Brazil? The elephant? I think Dr. Adams the visionary with Ventripoint will surprise us again with the upcoming FDA V4.0

good comment @cardinal true and not true. We will see sales right away as Hugh stated. He is closing the bigs now. The value of VMS 4.0 and our tech will be determined fairly quickly as well. Duke study with J&J and clarity on valves are massive. According to Hugh, cardiologists are now demanding VMS in some clinics. According to a key industry insider, whoever delivers the complete valve data will be worth billions. VMS just might have that

GranhamB the manipulative vulture and his gang of fake accounts are working hard to scare people here now, for many years on SH has denigrated Ventripoint dude no shares to save us LOL. Too funny to see the manipulation on TSX-V to scare small investors...sad person.

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide